Get the Stockscreener App
7.78
0.39%
0.03
Amneal Pharmaceuticals Inc Stock (AMRX) Forecast
The Amneal Pharmaceuticals Inc (AMRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.4227, representing a -4.59% decrease from the current price of $7.78. The highest analyst price target is $7.9446, and the lowest is $6.9007.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AMRX Price Target
Average 8.5907
(+10.42% Upside)
Is Amneal Pharmaceuticals Inc (AMRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.52 | Neutral |
| STOCH(9,6) | 17.29 | Buy |
| STOCHRSI(14) | 22.52 | Neutral |
| MACD(12,26) | -0.201 | Sell |
| ADX(14) | 21.86 | Neutral |
| William %R | -84.21 | Buy |
| CCI(14) | -84.29 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.913
Sell
|
7.9387
Sell
|
| MA20 |
8.188
Sell
|
8.1161
Sell
|
| MA50 |
8.4222
Sell
|
8.2844
Sell
|
| MA100 |
8.3281
Sell
|
8.1053
Sell
|
| MA200 |
7.3864
Buy
|
7.4003
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, AMRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on AMRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.52 indicates that AMRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.29 indicates that AMRX is oversold. This indicates that AMRX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 22.52 indicates that AMRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.86 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -84.29 indicates that AMRX is still oversold but not to an extreme extent.
Long-term AMRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Amneal Pharmaceuticals Inc financial reports and earnings history, Amneal Pharmaceuticals Inc (AMRX) stock could reach $20.22 by 2030, $57.04 by 2040 and $72.64 by 2050. See the projected annual prices until 2050 of the Amneal Pharmaceuticals Inc stock below:
- Amneal Pharmaceuticals Inc (AMRX) is expected to reach an average price of $26.99 in 2035, with a high prediction of $27.05 and a low estimate of $25.41. This indicates an $246.93% rise from the last recorded price of $7.78.
- Amneal Pharmaceuticals Inc (AMRX) stock is projected to chart a bullish course in 2040, with an average price target of $56.65, representing an $628.12% surge from its current level. The forecast ranges from a conservative $54.62 to a sky-high $57.04.
- Our analysts predict Amneal Pharmaceuticals Inc (AMRX) to jump 757.66% by 2045, soaring from $63.92 to an average price of $66.73, potentially reaching $66.77. While $63.92 is the low estimate, the potential upside is significant.
- Amneal Pharmaceuticals Inc (AMRX) stock is expected to climb by 2050, reaching an average of $72.31, a $829.41% jump from its current level. However, a wide range of estimates exists, with high and low targets of $72.64 and $70.65, respectively, highlighting the market's uncertainty.
Amneal Pharmaceuticals Inc Stock (AMRX) Year by Year Forecast
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2025
Amneal Pharmaceuticals Inc Stock (AMRX) is expected to reach an average price of $8.5907 in 2025, with a high prediction of $10.67 and a low estimate of $6.5065. This indicates an +10.42% rise from the last recorded price of $7.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.8846 | $6.9007 | $7.9446 | +1.35% |
| February, 2025 | $8.0125 | $7.5816 | $8.3286 | +2.99% |
| March, 2025 | $9.5704 | $7.9795 | $9.6104 | +23.01% |
| April, 2025 | $9.4352 | $9.1082 | $10.14 | +21.27% |
| May, 2025 | $9.953 | $9.2341 | $10.14 | +27.93% |
| June, 2025 | $9.5509 | $9.1439 | $10.28 | +22.76% |
| July, 2025 | $9.8157 | $9.4379 | $10.67 | +26.17% |
| August, 2025 | $10.06 | $9.5296 | $10.59 | +29.33% |
| September, 2025 | $6.6918 | $6.5065 | $9.035 | -13.99% |
| October, 2025 | $7.4914 | $6.6658 | $7.5514 | -3.71% |
| November, 2025 | $8.1271 | $7.3654 | $8.2371 | +4.46% |
| December, 2025 | $9.1568 | $8.1111 | $9.1818 | +17.70% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2026
The predicted value for Amneal Pharmaceuticals Inc (AMRX) in 2026 is set at an average of $11.70. Estimates vary from a peak of $15.00 to a trough of $8.4007, indicating an +50.37% surge from the present price of $7.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.4325 | $8.4007 | $9.8286 | +21.24% |
| February, 2026 | $10.22 | $9.4704 | $11.17 | +31.34% |
| March, 2026 | $10.47 | $10.22 | $11.03 | +34.63% |
| April, 2026 | $10.81 | $10.50 | $11.52 | +38.99% |
| May, 2026 | $11.48 | $10.44 | $11.54 | +47.55% |
| June, 2026 | $11.71 | $11.20 | $11.98 | +50.58% |
| July, 2026 | $13.74 | $11.71 | $13.97 | +76.67% |
| August, 2026 | $13.38 | $13.03 | $13.84 | +71.98% |
| September, 2026 | $13.96 | $13.23 | $14.19 | +79.43% |
| October, 2026 | $13.88 | $13.28 | $14.42 | +78.35% |
| November, 2026 | $14.11 | $13.91 | $14.89 | +81.38% |
| December, 2026 | $11.26 | $10.97 | $15.00 | +44.73% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Amneal Pharmaceuticals Inc (AMRX) is $13.46, with a high forecast of $17.81 and a low forecast of $9.1035. This indicates an +72.98% increase from the last price of $7.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.4336 | $9.1035 | $9.5036 | +21.25% |
| February, 2027 | $10.28 | $9.4445 | $10.34 | +32.10% |
| March, 2027 | $11.31 | $10.18 | $11.36 | +45.39% |
| April, 2027 | $12.19 | $11.22 | $12.21 | +56.62% |
| May, 2027 | $12.57 | $11.46 | $12.94 | +61.55% |
| June, 2027 | $13.72 | $12.64 | $14.39 | +76.39% |
| July, 2027 | $14.25 | $13.70 | $14.36 | +83.12% |
| August, 2027 | $14.30 | $14.11 | $14.98 | +83.81% |
| September, 2027 | $15.08 | $13.98 | $15.43 | +93.89% |
| October, 2027 | $15.85 | $15.10 | $15.88 | +103.71% |
| November, 2027 | $17.58 | $15.78 | $17.81 | +125.99% |
| December, 2027 | $17.27 | $16.94 | $17.72 | +121.93% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2028
In 2028, Amneal Pharmaceuticals Inc (AMRX) is projected to reach an average price of $15.55, with a high projection of $19.40 and a low estimate of $11.70. This indicates an +99.88% rise from the last price of $7.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $18.04 | $17.23 | $18.24 | +131.88% |
| February, 2028 | $18.06 | $17.41 | $18.55 | +132.18% |
| March, 2028 | $18.39 | $18.12 | $19.10 | +136.35% |
| April, 2028 | $13.83 | $13.54 | $19.40 | +77.76% |
| May, 2028 | $12.18 | $11.70 | $12.30 | +56.55% |
| June, 2028 | $13.17 | $12.33 | $13.28 | +69.29% |
| July, 2028 | $14.23 | $13.25 | $14.28 | +82.93% |
| August, 2028 | $15.35 | $14.17 | $15.41 | +97.32% |
| September, 2028 | $15.85 | $15.28 | $16.05 | +103.76% |
| October, 2028 | $16.99 | $15.85 | $17.61 | +118.44% |
| November, 2028 | $17.81 | $17.05 | $18.14 | +128.97% |
| December, 2028 | $17.52 | $17.49 | $18.44 | +125.26% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2029
The 2029 price forecast for Amneal Pharmaceuticals Inc Stock (AMRX) is $19.05 on average, with a high prediction of $23.80 and a low estimate of $14.30. This represents an +144.87% increase from the previous price of $7.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $19.12 | $17.52 | $19.27 | +145.81% |
| February, 2029 | $20.09 | $18.97 | $20.27 | +158.17% |
| March, 2029 | $21.45 | $19.59 | $21.65 | +175.67% |
| April, 2029 | $21.24 | $20.86 | $21.69 | +172.99% |
| May, 2029 | $21.95 | $21.23 | $22.35 | +182.11% |
| June, 2029 | $22.93 | $21.55 | $23.32 | +194.72% |
| July, 2029 | $22.71 | $22.60 | $23.28 | +191.91% |
| August, 2029 | $14.41 | $14.30 | $23.80 | +85.28% |
| September, 2029 | $14.88 | $14.40 | $15.00 | +91.31% |
| October, 2029 | $16.51 | $15.06 | $16.52 | +112.19% |
| November, 2029 | $17.18 | $16.48 | $17.36 | +120.79% |
| December, 2029 | $18.41 | $17.34 | $18.47 | +136.59% |
Amneal Pharmaceuticals Inc Stock (AMRX) Price Forecast for 2030
Amneal Pharmaceuticals Inc Stock (AMRX) is expected to reach an average price of $22.55 in 2030, with a high forecast of $28.21 and a low forecast of $16.89. This signifies an +189.86% surge from the last price of $7.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $20.06 | $18.36 | $20.22 | +157.85% |
| February, 2030 | $20.58 | $19.80 | $20.83 | +164.53% |
| March, 2030 | $21.22 | $20.40 | $21.55 | +172.74% |
| April, 2030 | $21.04 | $21.01 | $21.90 | +170.42% |
| May, 2030 | $22.77 | $21.06 | $22.92 | +192.71% |
| June, 2030 | $23.84 | $22.67 | $24.03 | +206.45% |
| July, 2030 | $24.86 | $23.38 | $25.49 | +219.49% |
| August, 2030 | $25.52 | $24.78 | $25.67 | +227.96% |
| September, 2030 | $26.05 | $25.42 | $26.45 | +234.89% |
| October, 2030 | $27.27 | $25.68 | $27.53 | +250.50% |
| November, 2030 | $27.62 | $26.90 | $27.86 | +254.99% |
| December, 2030 | $17.01 | $16.89 | $28.21 | +118.66% |
1.61%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):